Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Behaviors and Mental Disorders

Breast Neoplasms

Quality of Life

Micronutrients

All Drugs and Chemicals

Central Nervous System Depressants

Anti-Infective Agents

Herbal and Botanical

Other Dietary Supplements

Ubiquinone

Coenzyme Q10

Melatonin

Ethanol

Antioxidants

Protective Agents

Trace Elements

Vitamins

Reishi

Subjects will be dosed with Reishi mushroom extract, Coenzyme Q10 and Melatonin beginning with Cycle 1 Day 1 of their prescribed neoadjuvant chemotherapy.

Subjects will be dosed with Reishi mushroom extract, Coenzyme Q10 and Melatonin beginning with Cycle 3 Day 1 of their prescribed neoadjuvant chemotherapy.

Reishi mushroom preparation produced water-ethanol extraction.

Reishi mushroom extract

Christina Shannon, ND

This study is examine the effect of the addition of naturopathic on immunologic and/or inflammatory parameters and/or quality of life in women receiving neoadjuvant chemotherapy for breast cancer.

Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer

A Comparison Study to Assess the Value of Naturopathic Medicine Given Immediately and Continuously or Delayed Until Cycle 3 in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer

Subject quality of life as measured by a self-administered questionnaire (0 to 10 Likert scale with 0=No Effect to 10=Worst Effect) at each study visit. The symptoms or impact on activities scored included: Pain, Fatigue, Nausea, Sleep Disturbance, Distress, Shortness of Breath, Memory/Recall Problems, Appetite, Drowsiness, Dry Mouth, Sadness, Vomiting, Numbness, General Activities, Mood, Work, Relationships, Walking or Enjoyment.

The serum concentration of C-reactive protein will be measured by approved methods.

The serum concentration of circulating tumor cells will be measured by approved methods.

The erythrocyte sedimentation rate will be measured by approved methods.

Midwestern Regional Medical Center

Adverse event information was solicited from study subjects at each study visit. CTCAE 4.03 was used to grade adverse events.

Subjects will be dosed with Reishi mushroom extract, Coenzyme Q10 and Melatonin beginning with Cycle 1 Day 1 of their prescribed neoadjuvant chemotherapy.

Reishi mushroom extract: Reishi mushroom preparation produced water-ethanol extraction.

Coenzyme Q10: Preparation of coenzyme Q10

Melatonin: Preparation of melatonin

Immediate and Continuous Dosing

Subjects will be dosed with Reishi mushroom extract, Coenzyme Q10 and Melatonin beginning with Cycle 3 Day 1 of their prescribed neoadjuvant chemotherapy.

Reishi mushroom extract: Reishi mushroom preparation produced water-ethanol extraction.

Coenzyme Q10: Preparation of coenzyme Q10

Melatonin: Preparation of melatonin

Delayed Dosing

Total

Age, Categorical

Sex: Female, Male

Ethnicity (NIH/OMB)

Race (NIH/OMB)

United States

Region of Enrollment

Director of ClinicalResearch

Worst Pain (Visit 1)

Worst pain (Visit 2)

Worst Pain (Visit 3)

Worst Pain (Visit 4)

Worst Pain (Visit 5)

Worst Fatigue (Visit 1)

Worst Fatigue (Visit 2)

Worst Fatigue (Visit 3)

Worst Fatigue (Visit 4)

Worst Fatigue (Visit 5)

Worst Nausea (Visit 1)

Worst Nausea (Visit 2)

Worst Nausea (Visit 3)

Worst Nausea (Visit 4)

Worst Nausea (Visit 5)

Worst Sleep Disturbance (Visit 1)

Worst Sleep Disturbance (Visit 2)

Worst Sleep Disturbance (Visit 3)

Worst Sleep Disturbance (Visit 4)

Worst Sleep Disturbance (Visit 5)

Worst Sleep Distress (Visit 1)

Worst Sleep Distress (Visit 2)

Worst Sleep Distress (Visit 3)

Worst Sleep Distress (Visit 4)

Worst Sleep Distress (Visit 5)

Worst Shortness of Breath (Visit 1)

Worst Shortness of Breath (Visit 2)

Worst Shortness of Breath (Visit 3)

Worst Shortness of Breath (Visit 4)

Worst Shortness of Breath (Visit 5)

Worst Memory/Recall (Visit 1)

Worst Memory/Recall (Visit 2)

Worst Memory/Recall (Visit 3)

Worst Memory/Recall (Visit 4)

Worst Memory/Recall (Visit 5)

Worst Appetite (Visit 1)

Worst Appetite (Visit 2)

Worst Appetite (Visit 3)

Worst Appetite (Visit 4)

Worst Appetite (Visit 5)

Worst Drowsiness (Visit 1)

Worst Drowsiness (Visit 2)

Worst Drowsiness (Visit 3)

Worst Drowsiness (Visit 4)

Worst Drowsiness (Visit 5)

Worst Dry Mouth (Visit 1)

Worst Dry Mouth (Visit 2)

Worst Dry Mouth (Visit 3)

Worst Dry Mouth (Visit 4)

Worst Dry Mouth (Visit 15

Worst Sadness (Visit 1)

Worst Sadness (Visit 2)

Worst Sadness (Visit 3)

Worst Sadness (Visit 4)

Worst Sadness (Visit 5)

Worst Vomiting (Visit 1)

Worst Vomiting (Visit 2)

Worst Vomiting (Visit 3)

Worst Vomiting (Visit 4)

Worst Vomiting (Visit 5)

Worst Numbness (Visit 1)

Worst Numbness (Visit 2)

Worst Numbness (Visit 3)

Worst Numbness (Visit 4)

Worst Numbness (Visit 5)

Worst Effect on General Activities (Visit 1)

Worst Effect on General Activities (Visit 2)

Worst Effect on General Activities (Visit 3)

Worst Effect on General Activities (Visit 4)

Worst Effect on General Activities (Visit 5)

Worst Mood (Visit 1)

Worst Mood (Visit 2)

Worst Mood (Visit 3)

Worst Mood (Visit 4)

Worst Mood (Visit 5)

Worst Effect on Work (Visit 1)

Worst Effect on Work (Visit 2)

Worst Effect on Work (Visit 3)

Worst Effect on Work (Visit 4)

Worst Effect on Work (Visit 5)

Worst Effect on Relationships (Visit 1)

Worst Effect on Relationships (Visit 2)

Worst Effect on Relationships (Visit 3)

Worst Effect on Relationships (Visit 4)

Worst Effect on Relationships (Visit 5)

Worst Walking (Visit 1)

Worst Walking (Visit 2)

Worst Walking (Visit 3)

Worst Walking (Visit 4)

Worst Walking (Visit 5)

Worst Effect on Enjoyment (Visit 1)

Worst Effect on Enjoyment (Visit 2)

1Worst Effect on Enjoyment (Visit 3)

Worst Effect on Enjoyment (Visit 4)

Worst Effect on Enjoyment (Visit 5)

One subject in the 'Delayed' arm withdrew consent following Study Visit 2. One subject in the 'Immediate' arm did not complete the Quality of Life Questionnaire at Visit 2. One subject in the 'Delayed' arm did not complete the Quality of Life Questionnaire at Visit 5. One subject in the 'Immediate' Arm withdrew consent prior to completing Visit 5.

Subject Reported Quality of Life Score

Visit 1

Visit 2

Visit 3

Visit 4

Visit 5

C-reactive protein was not determined for one subject in the 'Immediate' Arm at Visit 1, one subject in the 'Delayed' Arm at Visit 2 and one subject in the 'Immediate' Arm at Visit 3 due to blood sample not collected. One subject in each arm withdrew consent after visits 2 and 4, respectively.

Concentration of C-reactive Protein in Serum (mg/L)

Circulating tumor cells were not determined for one subject in the 'Immediate' Arm at Visit 1, one subject in the 'Delayed' Arm at Visit 2 and one subject in the 'Immediate' Arm at Visit 3 due to blood sample not collected. One subject in each arm withdrew consent after visits 2 and 4, respectively.

Concentration of Circulating Tumor Cells in Blood (Cells Per Milliliter)

Sedimentation rate was not determined for one subject in the 'Immediate' Arm at Visit 1, one subject in the 'Delayed' Arm at Visit 2 and one subject in the 'Immediate' Arm at Visit 3 due to blood sample not collected. One subject in each arm withdrew consent after visits 2 and 4, respectively.

Sedimentation Rate of Erythrocytes in Blood (mm/hr)

Overall Study

Symptoms and General Pathology

Blood and Lymph Conditions

Rare Diseases

Syndrome

Cytopenia

Preleukemia

Myelodysplastic Syndromes

Bone Marrow Diseases

Hematologic Diseases

Precancerous Conditions

Anti-Inflammatory Agents

Antineoplastic Agents

Antirheumatic Agents

Analgesics

Curcumin

Anti-Inflammatory Agents, Non-Steroidal

Analgesics, Non-Narcotic

Enzyme Inhibitors

curcumin; coenzyme q10

moshe e gatt, dr

To determine the clinical effects of coenzyme Q10 and Curcumin in improving the cytopenias of patients with myelodysplastic syndromes. we propose to explore the efficacy of the natural compounds curcumin and CoQ10 in MDS because these two agents possess many of the effects that are desirable in MDS.

The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes

A Pilot Study to Determine the Clinical Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer	NCT02486796	Quality of Life	Reishi mushroom... Coenzyme Q10 Melatonin	18 Years -	Midwestern Regional Medical Center
The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes	NCT00247026	Myelodysplastic...	curcumin; coenz...	16 Years -	Hadassah Medical Organization
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer	NCT02486796	Quality of Life	Reishi mushroom... Coenzyme Q10 Melatonin	18 Years -	Midwestern Regional Medical Center
Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome	NCT01910766	Polycystic Ovar...	Coenzyme Q10 clomiphene citr...	-	Mansoura University
Coenzyme Q10 and Dentoalveolar Cyst	NCT05873673	Cyst, Jaw	Coenzyme Q10 control group	18 Years -	Fayoum University
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer	NCT01964001	Hepatocellular ...	Vitamin B-6 Coenzyme Q10 Vitamin B-6+Coe... Placebo	20 Years - 80 Years	Taichung Veterans General Hospital

Spots Global Cancer Trial Database for coenzyme q10

Every month we try and update this database with for coenzyme q10 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.